PetMed Express Statistics
Total Valuation
PetMed Express has a market cap or net worth of $41.84 million. The enterprise value is $21.39 million.
| Market Cap | 41.84M |
| Enterprise Value | 21.39M |
Important Dates
The last earnings date was Tuesday, June 2, 2026, after market close.
| Earnings Date | Jun 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PetMed Express has 21.03 million shares outstanding. The number of shares has increased by 1.58% in one year.
| Current Share Class | 21.03M |
| Shares Outstanding | 21.03M |
| Shares Change (YoY) | +1.58% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 7.68% |
| Owned by Institutions (%) | 24.89% |
| Float | 13.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 28.50 |
| PS Ratio | 0.24 |
| Forward PS | 0.17 |
| PB Ratio | 1.46 |
| P/TBV Ratio | 1.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.02.
| Current Ratio | 0.84 |
| Quick Ratio | 0.45 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -100.44% and return on invested capital (ROIC) is -389.74%.
| Return on Equity (ROE) | -100.44% |
| Return on Assets (ROA) | -15.44% |
| Return on Invested Capital (ROIC) | -389.74% |
| Return on Capital Employed (ROCE) | -201.23% |
| Weighted Average Cost of Capital (WACC) | 8.43% |
| Revenue Per Employee | $947,201 |
| Profits Per Employee | -$303,101 |
| Employee Count | 189 |
| Asset Turnover | 1.56 |
| Inventory Turnover | 8.64 |
Taxes
| Income Tax | -73,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.38% in the last 52 weeks. The beta is 0.78, so PetMed Express's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -43.38% |
| 50-Day Moving Average | 1.95 |
| 200-Day Moving Average | 2.46 |
| Relative Strength Index (RSI) | 54.59 |
| Average Volume (20 Days) | 176,643 |
Short Selling Information
The latest short interest is 914,046, so 4.35% of the outstanding shares have been sold short.
| Short Interest | 914,046 |
| Short Previous Month | 1.62M |
| Short % of Shares Out | 4.35% |
| Short % of Float | 6.73% |
| Short Ratio (days to cover) | 0.54 |
Income Statement
In the last 12 months, PetMed Express had revenue of $179.02 million and -$57.29 million in losses. Loss per share was -$2.74.
| Revenue | 179.02M |
| Gross Profit | 50.22M |
| Operating Income | -28.39M |
| Pretax Income | -57.36M |
| Net Income | -57.29M |
| EBITDA | -49.29M |
| EBIT | -58.67M |
| Loss Per Share | -$2.74 |
Balance Sheet
The company has $21.41 million in cash and $535,000 in debt, with a net cash position of $20.88 million or $0.99 per share.
| Cash & Cash Equivalents | 21.41M |
| Total Debt | 535,000 |
| Net Cash | 20.88M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 28.94M |
| Book Value Per Share | 1.37 |
| Working Capital | -8.47M |
Cash Flow
In the last 12 months, operating cash flow was -$28.39 million and capital expenditures -$4.62 million, giving a free cash flow of -$33.01 million.
| Operating Cash Flow | -28.39M |
| Capital Expenditures | -4.62M |
| Depreciation & Amortization | 9.39M |
| Net Borrowing | n/a |
| Free Cash Flow | -33.01M |
| FCF Per Share | -$1.57 |
Margins
Gross margin is 28.05%, with operating and profit margins of -15.86% and -32.00%.
| Gross Margin | 28.05% |
| Operating Margin | -15.86% |
| Pretax Margin | -32.04% |
| Profit Margin | -32.00% |
| EBITDA Margin | -27.53% |
| EBIT Margin | -32.77% |
| FCF Margin | n/a |
Dividends & Yields
PetMed Express does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.58% |
| Shareholder Yield | -1.58% |
| Earnings Yield | -135.54% |
| FCF Yield | -78.10% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 4, 1999. It was a forward split with a ratio of 3:1.
| Last Split Date | Mar 4, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
PetMed Express has an Altman Z-Score of 1.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 2 |